查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1574960

腹腔感染市場，按診斷、按應用、按治療、按國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Intra-Abdominal Infections Market, By Diagnosis, By Application, By Treatment, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年腹腔感染市場規模為 225.9043 億美元，2024 年至 2032 年複合年成長率為 8.90%。

腹腔感染市場-市場動態

抗生素抗藥性的上升推動了對先進治療方案的需求。

抗生素抗藥性的上升增加了對更好的腹內感染治療方法的需求。隨著標準抗生素的有效性降低，醫療保健提供者難以控制這些感染。美國疾病管制與預防中心 (CDC) 報告稱，美國每年發生近 300 萬例抗生素抗藥性感染，凸顯了對新療法的迫切需求。這個問題不僅影響患者的健康，也對醫療保健系統造成沉重壓力。

為此，研究人員和製藥公司正在研究新的解決方案，包括新型抗生素和替代療法。我們的目標是開發這些先進的治療方法，以改善患者的治療效果並解決傳統方法無法治療的感染。這種轉變對於在抵抗力不斷上升的情況下確保更好的醫療保健至關重要。

腹腔內感染市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.90% 左右的複合年成長率成長

根據治療細分，預計 BETA-內醯胺將在 2023 年顯示出最大的市場佔有率

依應用細分，2023年腹腔內膿瘍為主導類型

基於診斷細分，電腦斷層掃描（CT）是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

腹腔內感染市場細分分析：

全球腹腔感染市場根據診斷、應用、治療和區域進行細分。

根據治療方法，市場分為三類：氯黴素、BETA內醯胺、喹諾酮類和氨基糖苷類。在腹腔內感染市場，BETA-內醯胺是領先的治療選擇。它們很受歡迎，因為它們可以有效地針對多種細菌，包括通常與這些感染相關的革蘭氏陽性和革蘭氏陰性細菌。

BETA-內醯胺類藥物，如青黴素和頭孢菌素，由於其有效性和良好的安全性記錄，通常是治療的首選。它們還可以輕鬆穿透組織，從而有效對抗腹內細菌。隨著越來越多的手術進行，導致感染率上升，對 BETA-內醯胺酶的需求持續成長，鞏固了其在該細分市場的領先地位。

市場依應用分為五類：腹內膿瘍、闌尾炎、憩室炎、腹瀉、食物中毒、幽門螺旋桿菌感染等。在腹內感染市場中，最主要的部分是腹內膿瘍。這些在臨床環境中很常見，通常是作為闌尾炎和憩室炎等疾病的併發症而發生。腹內膿瘍可能導致敗血症等問題，因此快速有效的治療至關重要。治療這些感染的手術和抗生素治療的需求也推動了市場的成長。

腹腔內感染市場 - 地理洞察

腹腔內感染市場最大的地區是北美洲。該地區擁有大量醫院和先進的醫療保健系統，可支持這些感染的診斷和治療。外科手術的增加和肥胖盛行率的增加導致腹腔內感染的增加。

在主要醫療保健公司的推動下，新療法的研究和發展也很活躍。患者可以獲得抗生素和其他療法。由於感染管理意識的增強和一些因素的影響，北美市場預計將成長。

腹腔內感染市場-競爭格局：

腹腔內感染市場有許多專注於開發針對這些疾病的有效治療方法的參與者。默克公司在一系列抗生素和創新療法方面處於領先地位。輝瑞公司提供多種有效藥物，而阿斯特捷利康則以其在該領域的研究而聞名。

艾伯維公司（AbbVie Inc.）專注於對抗感染的標靶療法，拜耳公司（Bayer AG）提供全面治療和支持性護理。葛蘭素史克（GlaxoSmithKline）也致力於投資新藥發現。隨著人們對腹腔內感染的認知不斷增強，這些公司競相改進現有產品並推出新療法，推動市場成長。

最新進展：

2024 年 1 月，NPPA 降低了 Cipla 和 Wockhardt 專利到期後抗生素的價格，旨在提高患者的可及性和負擔能力。

2023年1月，BDR Pharmaceuticals推出了一種新的學名藥抗生素頭孢他啶+阿維巴坦，旨在對抗革蘭氏陰性菌感染。這種組合旨在增強針對具有挑戰性的細菌病原體的治療選擇，解決對抗生素抗藥性日益成長的擔憂。

目錄

第1章：腹腔內感染市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 腹腔內感染診斷市場片段
    • 按應用分類的腹內感染市場片段
    • 腹腔內感染治療市場片段
    • 按國家/地區分類的腹腔內感染市場片段
    • 按地區分類的腹腔內感染市場片段
  • 競爭洞察

第 3 章：腹腔內感染主要市場趨勢

  • 腹腔內感染市場促進因素
    • 市場促進因素的影響分析
  • 腹腔內感染市場限制
    • 市場限制影響分析
  • 腹腔內感染市場機會
  • 腹腔感染市場未來趨勢

第 4 章：腹腔內感染產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：腹腔內感染市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：腹腔內感染市場格局

  • 2023 年腹內感染市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：腹腔內感染市場 - 透過診斷

  • 概述
    • 透過診斷進行細分市場佔有率分析
    • 腹部X光檢查
    • 血液檢查
    • 電腦斷層掃描 (CT)
    • 超音波
    • 其他

第 8 章：腹腔內感染市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 腹內膿腫
    • 闌尾炎
    • 憩室炎
    • 腹瀉
    • 食物中毒
    • 幽門螺旋桿菌感染
    • 其他

第 9 章：腹腔內感染市場 - 依治療方法

  • 概述
    • 按處理方式分類的細分市場佔有率分析
    • 氯黴素
    • BETA內醯胺
    • 奎諾酮類
    • 氨基糖苷類
    • 其他

第 10 章：腹腔內感染市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美腹腔感染主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按診斷）
    • 北美市場規模和預測（按應用）
    • 北美市場規模與預測（以不同處理方式）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲腹腔感染主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（透過診斷）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模與預測（按處理方式）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區腹腔感染主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模及預測（依診斷）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模與預測（以不同處理方式）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲腹腔感染主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按診斷）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模與預測（以不同處理方式）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲腹腔感染主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按診斷）
    • 中東和非洲市場規模及預測（按應用）
    • 中東及非洲市場規模及預測（依不同處理方式）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 腹腔內感染產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • Merck & Co., Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Allergan (AbbVie)
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • Sanofi SA
    • F. Hoffmann-La Roche Ltd
    • Johnson & Johnson
    • Basilea Pharmaceutica Ltd
    • Shionogi & Co., Ltd.
    • Achaogen, Inc.
    • Melinta Therapeutics, Inc.
    • Tetraphase Pharmaceuticals, Inc.
    • The Medicines Company
    • Dr. Reddy's Laboratories Ltd

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4001

REPORT HIGHLIGHT

Intra-Abdominal Infections Market size was valued at USD 22,590.43 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The intra-abdominal infections market involves products and treatments for infections occurring inside the abdomen. These infections can affect organs like the stomach, intestines, and liver. They are often caused by bacteria and can lead to serious health issues if not treated promptly. The market includes antibiotics, surgical procedures, and medical devices used to manage these infections. With rising cases of obesity and other health conditions, the demand for effective treatments is growing. Overall, this market plays a crucial role in improving patient outcomes and healthcare quality.

Intra-Abdominal Infections Market- Market Dynamics

Rising antibiotic resistance fuels the demand for advanced treatment options.

Rising antibiotic resistance is increasing the demand for better treatments for intra-abdominal infections. As standard antibiotics become less effective, healthcare providers struggle to manage these infections. The Centres for Disease Control and Prevention (CDC) report that nearly 3 million antibiotic-resistant infections happen in the U.S. each year, highlighting the urgent need for new therapies. This issue not only affects patients' health but also puts a heavy strain on healthcare systems.

In response, researchers and pharmaceutical companies are working on new solutions, including novel antibiotics and alternative therapies. The goal is to develop these advanced treatments to improve patient outcomes and tackle infections that traditional methods can't manage anymore. This shift is crucial for ensuring better healthcare in the face of rising resistance.

Intra-Abdominal Infections Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Treatment segmentation, Beta-lactams was predicted to show maximum market share in the year 2023

Based on Application segmentation, Intra-Abdominal Abscesses was the leading type in 2023

Based on Diagnosis segmentation, Computed Tomography (CT) was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Intra-Abdominal Infections Market- Segmentation Analysis:

The Global Intra-Abdominal Infections Market is segmented based on Diagnosis, Application, Treatment, and Region.

The market is divided into three categories based on Treatment: Chloramphenicol, Beta Lactams, Quinolones, and Aminoglycosides. In the Intra-Abdominal Infections market, Beta-lactams are the leading treatment option. They are popular because they effectively target a wide range of bacteria, including both gram-positive and gram-negative types commonly associated with these infections.

Beta-lactams, such as penicillin and cephalosporins, are often the first choice for treatment due to their effectiveness and good safety record. They can also penetrate tissues easily, making them effective against intra-abdominal germs. As more surgeries are performed, leading to a rise in infections, the demand for Beta-lactamases continues to grow, reinforcing their top position in this market segment.

The market is divided into five categories based on Application: Intra-abdominal Abscess, Appendicitis, Diverticulitis, diarrhea, Food Poisoning, Infection by Helicobacter Pylori, and Others. In the Intra-Abdominal Infections market, the most dominant segment is Intra-Abdominal Abscesses. These are common in clinical settings and often occur as complications from conditions like appendicitis and diverticulitis. Intra-abdominal abscesses can lead to issues, such as sepsis, which makes quick and effective treatment essential. The need for surgery and antibiotic therapy to treat these infections also boost the market.

Intra-Abdominal Infections Market- Geographical Insights

The largest region in the Intra-Abdominal Infections market is North America. This area has a high number of hospitals and advanced healthcare systems, which support the diagnosis and treatment of these infections. The rise in surgical procedures and the increasing prevalence of obesity are leading to more intra-abdominal infections.

There is also strong research and development in new treatments, driven by major healthcare companies. Patients have access to antibiotics and other therapies. The North American market is expected to grow due to increasing awareness of infection management and several contributing factors.

Intra-Abdominal Infections Market- Competitive Landscape:

The intra-abdominal infections market features several players focused on developing effective treatments for these conditions. Merck & Co. leads with a range of antibiotics and innovative therapies. Pfizer Inc. offers a variety of effective medications, while AstraZeneca is known for its research in this field.

AbbVie Inc. focuses on targeted therapies to combat infections, and Bayer AG provides a mix of treatments and supportive care. GSK (GlaxoSmithKline) is also committed to investing in new drug discoveries. As awareness of intra-abdominal infections grows, these companies compete to improve existing products and introduce new therapies, driving market growth.

Recent Developments:

In January 2024, The NPPA reduced prices of antibiotics from Cipla and Wockhardt following their off-patent status, aiming to enhance accessibility and affordability for patients.

In January 2023, BDR Pharmaceuticals launched a new generic antibiotic, Ceftazidime + Avibactam, designed to combat gram-negative infections. This combination aims to enhance treatment options for challenging bacterial pathogens, addressing growing concerns over antibiotic resistance.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Allergan (AbbVie)
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Basilea Pharmaceutica Ltd
  • Shionogi & Co., Ltd.
  • Achaogen, Inc.
  • Melinta Therapeutics, Inc.
  • Tetraphase Pharmaceuticals, Inc.
  • The Medicines Company
  • Dr. Reddy's Laboratories Ltd

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Abdominal X-ray
  • Blood Tests
  • Computed Tomography (CT)
  • Ultrasound

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Intra-abdominal Abscess
  • Appendicitis
  • Diverticulitis
  • Diarrhea
  • Food Poisoning
  • Infection by Helicobacter Pylori
  • Others

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Chloramphenicol
  • Beta Lactams
  • Quinolones
  • Aminoglycosides
  • Others

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Intra-Abdominal Infections Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Intra-Abdominal Infections Market Snippet by Diagnosis
    • 2.1.2. Intra-Abdominal Infections Market Snippet by Application
    • 2.1.3. Intra-Abdominal Infections Market Snippet by Treatment
    • 2.1.4. Intra-Abdominal Infections Market Snippet by Country
    • 2.1.5. Intra-Abdominal Infections Market Snippet by Region
  • 2.2. Competitive Insights

3. Intra-Abdominal Infections Key Market Trends

  • 3.1. Intra-Abdominal Infections Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Intra-Abdominal Infections Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Intra-Abdominal Infections Market Opportunities
  • 3.4. Intra-Abdominal Infections Market Future Trends

4. Intra-Abdominal Infections Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Intra-Abdominal Infections Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Intra-Abdominal Infections Market Landscape

  • 6.1. Intra-Abdominal Infections Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Intra-Abdominal Infections Market - By Diagnosis

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 7.1.2. Abdominal X-ray
    • 7.1.3. Blood Tests
    • 7.1.4. Computed Tomography (CT)
    • 7.1.5. Ultrasound
    • 7.1.6. Others

8. Intra-Abdominal Infections Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Intra-abdominal Abscess
    • 8.1.3. Appendicitis
    • 8.1.4. Diverticulitis
    • 8.1.5. Diarrhoea
    • 8.1.6. Food Poisoning
    • 8.1.7. Infection by Helicobacter Pylori
    • 8.1.8. Others

9. Intra-Abdominal Infections Market - By Treatment

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 9.1.2. Chloramphenicol
    • 9.1.3. Beta Lactams
    • 9.1.4. Quinolones
    • 9.1.5. Aminoglycosides
    • 9.1.6. Others

10. Intra-Abdominal Infections Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Intra-Abdominal Infections Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Intra-Abdominal Infections Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Intra-Abdominal Infections Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Intra-Abdominal Infections Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Intra-Abdominal Infections Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Intra-Abdominal Infections Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Merck & Co., Inc.
    • 11.2.3. AstraZeneca PLC
    • 11.2.4. Bayer AG
    • 11.2.5. Allergan (AbbVie)
    • 11.2.6. GlaxoSmithKline plc
    • 11.2.7. Eli Lilly and Company
    • 11.2.8. Sanofi S.A.
    • 11.2.9. F. Hoffmann-La Roche Ltd
    • 11.2.10. Johnson & Johnson
    • 11.2.11. Basilea Pharmaceutica Ltd
    • 11.2.12. Shionogi & Co., Ltd.
    • 11.2.13. Achaogen, Inc.
    • 11.2.14. Melinta Therapeutics, Inc.
    • 11.2.15. Tetraphase Pharmaceuticals, Inc.
    • 11.2.16. The Medicines Company
    • 11.2.17. Dr. Reddy's Laboratories Ltd

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us